208 related articles for article (PubMed ID: 20002290)
1. Use of deodorants during adjuvant breast radiotherapy: a survey of compliance with standard advice, impact on patients and a literature review on safety.
Graham PH; Graham JL
J Med Imaging Radiat Oncol; 2009 Dec; 53(6):569-73. PubMed ID: 20002290
[TBL] [Abstract][Full Text] [Related]
2. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial.
Théberge V; Harel F; Dagnault A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1048-52. PubMed ID: 19327906
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effects of aluminum-containing and non-aluminum containing deodorants on axillary skin toxicity during radiation therapy for breast cancer: a 3-armed randomized controlled trial.
Lewis L; Carson S; Bydder S; Athifa M; Williams AM; Bremner A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):765-71. PubMed ID: 25194668
[TBL] [Abstract][Full Text] [Related]
4. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
[TBL] [Abstract][Full Text] [Related]
5. Effective axillary malodour reduction by polyquaternium-16-containing deodorants.
Traupe B; Fölster H; Max H; Schulz J
Int J Cosmet Sci; 2017 Apr; 39(2):141-148. PubMed ID: 27506727
[TBL] [Abstract][Full Text] [Related]
6. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
7. The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and meta-analysis.
Salvestrini V; Marta GN; Caini S; Wolf JR; van den Hurk C; Beveridge M; Lam H; Bonomo P; Chow E; Behroozian T
Support Care Cancer; 2023 Mar; 31(3):198. PubMed ID: 36867303
[TBL] [Abstract][Full Text] [Related]
8. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
10. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
11. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
12. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Gothard L; Cornes P; Earl J; Hall E; MacLaren J; Mortimer P; Peacock J; Peckitt C; Woods M; Yarnold J
Radiother Oncol; 2004 Nov; 73(2):133-9. PubMed ID: 15542159
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results.
Rouëssé J; de la Lande B; Bertheault-Cvitkovic F; Serin D; Graïc Y; Combe M; Leduc B; Lucas V; Demange L; Nguyen TD; Castèra D; Krzisch C; Villet R; Mouret-Fourme E; Garbay JR; Noguès C;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1072-80. PubMed ID: 16504757
[TBL] [Abstract][Full Text] [Related]
15. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
16. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis from a natural deodorant: a report of 4 cases associated with lichen acid mix allergy.
Sheu M; Simpson EL; Law SV; Storrs FJ
J Am Acad Dermatol; 2006 Aug; 55(2):332-7. PubMed ID: 16844524
[TBL] [Abstract][Full Text] [Related]
19. A federal audit of the Belgian radiotherapy departments in breast cancer treatment.
Van Houtte P; Bourgois N; Renard F; Huget P; D'hoore W; Scalliet P;
Radiother Oncol; 2007 May; 83(2):178-86. PubMed ID: 17470379
[TBL] [Abstract][Full Text] [Related]
20. A long-term study of radiation therapy in t1-2 node-negative breast cancer patients in relation to the number of axillary nodes examined.
Tai P; Yu E; Sadikov E; Joseph K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):453-7. PubMed ID: 18947940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
